TickerFactsScreenerDevelopers

Vanda Pharmaceuticals Inc. (VNDA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: $169.34M2010: -$10.90M2011: -$28.41M2012: -$44.92M2013: -$39.59M2017: -$1.98M2018: $29.99M2019: $45.95M2020: $51.77M2021: $64.21M2022: $31.98M2023: $12.80M2024: -$15.76M2025: -$109.44M-$109.44M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$109.44M-594.6%
2024-$15.76M-223.1%
2023$12.80M-60.0%
2022$31.98M-50.2%
2021$64.21M+24.0%
2020$51.77M+12.7%
2019$45.95M+53.2%
2018$29.99M+1612.2%
2017-$1.98M—
2013-$39.59M+11.9%
2012-$44.92M-58.1%
2011-$28.41M-160.7%
2010-$10.90M-106.4%
2009$169.34M—